MD Anderson Cancer Center

Today, MD Anderson and Texas Children's Hospital launched a transformational collaboration with a singular focus: to end childhood cancer. This new first-of-its-kind joint venture will unite the nation’s largest comprehensive pediatric system and a top pediatric cancer program with the nation’s leading comprehensive cancer center. Through this unique collaboration, we will be able to impact even more young lives through improved patient access with unique clinical trials.? “The scope and scale of our combined effort will build the world’s preeminent pediatric cancer center, addressing the growing need for excellent patient care and greatly benefiting children with cancer through increased access to care and to clinical trials,” says MD Anderson President Peter Pisters. Collaborative operations and patient care will launch in early 2026, and it will expand access while offering the nation’s largest complement of pediatric subspecialty care and services to children diagnosed with all types of cancer within a single program. More than 200 Texas Children’s pediatric oncology specialists, who are full-time faculty with Baylor College of Medicine, and over 100 MD Anderson pediatric clinicians and researchers will together advance this transformational care team. ? Learn more: https://bit.ly/3X9VtOR #HealthCare #EndCancer?

Congratulations to our Dr. Lauren Byers and Dr. Paul Scheet on being elected AAAS Fellows. Learn more about this recognition. #EndCancer

"MD Anderson gave me that piece I was missing in my profession," says our Dr. David Ramirez. Read his story and how a medical rotation changed his life. #EndCancer

Congratulations to Jeffrey E. Lee, M.D. on his official appointment at MD Anderson’s Chief Medical Executive, effective April 1. "The opportunity to lead our incredibly talented team of clinicians, scientists and staff is a distinct honor,” Lee says. "Inspired by the needs of our patients and working under our shared mission, I’m committed to guiding our collective efforts to deliver powerful impact for our patients.” Learn about Dr. Lee’s 34-year tenure at MD Anderson, where he has made substantial contributions in oncology and served in multiple leadership roles: https://bit.ly/4cav61E #HealthCare #EndCancer

It was great to stop by MD Anderson Cancer Center's Employee Service Awards Festival this afternoon. Congratulations to all our teammates for your service milestones! Your unwavering dedication make MD Anderson a special place. Thank you for all you do. #EndCancer

Radiation alone may be enough for some patients with cervical cancer. A new study found no survival difference between those treated with chemoradiotherapy and those who received radiation alone after surgery. Learn more. #CancerResearch #EndCancer

Despite concerns about neurotoxicity, BCMA-directed CAR T cell therapy may be safe and effective for patients with relapsed/refractory multiple myeloma and CNS involvement. A recent study led by MD Anderson showed an 80% overall response rate and no excess neurotoxicity. Learn more. #CancerResearch #EndCancer

"Colorectal cancer is one of the few cancers where surgical technique plays a crucial role in oncologic outcomes," says our Dr. Tsuyoshi Konishi. Watch to discover why he moved from Tokyo to Houston to advance care for colorectal cancer patients. #EndCancer

Congratulations to MD Anderson President Peter Pisters on being recognized by Becker's Healthcare as one of the Great Leaders in Healthcare 2025. His strategic vision focuses on accelerating breakthroughs, expanding patient access, and advancing impactful science. #HealthCare #EndCancer

Research led by our Dr. Savitri Krishnamurthy showed that a digital pathology tool enables real-time, remote diagnosis of breast cancer, without the need for a microscope. Learn more. #EndCancer